Position in ADMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,769,110
+$8,130,863 QoQ
Shares Held
1,525,581
+196.4% QoQ
Ownership
0.681%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 323 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. ADMA ranks #40 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in ADMA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,769,110 | 1,525,581 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $4,638,247 | 514,789 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $5,585,214 | 306,207 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $4,033,829 | 275,159 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $8,374,431 | 459,881 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,314,576 | 519,888 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,092,380 | 530,168 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $11,780,365 | 589,313 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,646,677 | 773,406 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $5,391,888 | 816,953 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $2,672,236 | 591,203 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $1,940,513 | 542,043 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,667,167 | 451,807 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $461,129 | 139,314 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $476,661 | 122,851 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $180,296 | 74,196 | Shares | Defined | 2022-11-14 | |
| 2020-06-30 | $85,599 | 29,215 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||